Updated

Bar-Ilan University researchers used a three-drug combination of common medicines to treat mice with Latent Autoimmune Diabetes in Adults, sometimes called Type 1.5 diabetes, The Times of Israel reported. About 30 percent of the mice responded, and the team was able to predict which animals would respond. The researchers said the work could pave the way for personalized medical care for patients with the condition.